Common Warrants and Pre Funded Warrants (Tables)

6 Months Ended

Jun. 30, 2024

Class of Warrant or Right [Line Items]

Summary of Net Proceeds Received from Sale of Common Stock, Pre-Funded Warrants and Common Warrants

The Company used the with-and-without method to allocate the net proceeds received from the sale of the Common Stock, the Pre-Funded Warrants, and the Common Warrants on the Consolidated Balance Sheets as follows:

	As of October 25, 2023
Common Stock	$	18,641
Pre-Funded Warrants		48,079
Common Warrants		25,427
Total	$	92,147

Summary of Pre-funded Warrant Shares Outstanding

The following table summarizes information about shares issuable under the Pre-Funded Warrants outstanding at June 30, 2024:

	Pre-funded warrant shares outstanding
Outstanding at January 1, 2024		81,054,686
Issued		-
Exercised		(4,125,531	)
Outstanding at June 30, 2024		76,929,155
Exercisable at June 30, 2024		76,929,155

Summary of Common Warrant Liability

The following table sets forth a summary of the activities of the Company’s warrant liability, which represents a recurring measurement that is classified with Level 3 of the fair value hierarchy wherein the fair value is estimated using significant unobservable inputs:

	Common warrant liability
Beginning liability as of January 1, 2024	$	27,596
Common warrants issued		-
Change in fair value of liability		(16,106	)
Ending liability as of June 30, 2024	$	11,490

Summary of Common Warrant Shares Outstanding

The following table summarizes information about shares issuable under the Common Warrants outstanding at June 30, 2024:

	Common warrant shares outstanding
Outstanding at January 1, 2024		56,241,973
Issued		-
Exercised		-
Outstanding at June 30, 2024		56,241,973
Exercisable at June 30, 2024		56,241,973

Common Warrants [Member]

Class of Warrant or Right [Line Items]

Summary of Assumptions Used to Determine the fair value at Issuance and Reporting Date of Common Warrants Granted

The assumptions that the Company used to determine the fair value at issuance and the reporting date of the Common Warrants granted to participants were as follows:

	June 30, 2024			December 31, 2023
Expected term (in years)		6.33			6.83
Risk-free interest rate		4.27	%		3.88	%
Dividend yield		-			-
Volatility		77.54	%		82.80	%